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Natural history of limbs with arterial insufficiency
and chronic ulceration treated without
revascularization
William A. Marston, MD, Stephen W. Davies, BS, Brian Armstrong, BS, Mark A. Farber, MD,
Robert C. Mendes, MD, Joseph J. Fulton, MD, and Blair A. Keagy, MD, Chapel Hill, NC
Objectives: The natural history of limbs affected by ischemic ulceration is poorly understood. In this report, we describe
the outcome of limbs with stable chronic leg ulcers and arterial insufficiency that were treated with wound-healing
techniques in patients who were not candidates for revascularization.
Methods: A prospectively maintained database of limb ulcers treated at a comprehensive wound center was used to identify
patients with arterial insufficiency, defined as an ankle-brachial index (ABI)<0.7 or a toe pressure<50 mmHg. Patients
were treated without revascularization when medical comorbidity or anatomic considerations did not allow revascular-
ization with acceptable risk. Ulcers were treated with a protocol emphasizing pressure relief, débridement, infection
control, and moist wound healing. Risk factors analyzed for their affect on healing and amputation risk included age,
gender, diabetes mellitus, chronic renal insufficiency (serum creatinine > 2.5 mg/dL), severity of ischemia measured by
ABI or toe pressure, wound grade, wound size, and wound location.
Results: Between January 1999 and March 2005, 142 patients with 169 limbs having arterial insufficiency and
full-thickness ulceration were treated without revascularization. Mean patient age was 70.8 4.5. Diabetes mellitus was
present in 70.4% of limbs and chronic renal insufficiency in 27.8%. Toe amputations or other foot-sparing procedures
were performed in 28% of limbs. Overall, limb loss occurred in 37 patients. By life-table analysis, 19% of limbs required
amputation <6 months of initial treatment and 23% at 12 months. Complete wound closure was achieved in 25% by 6
months and in 52% by 12 months. Statistical analysis showed a correlation between ABI and the risk of limb loss. In
patients with an ABI<0.5, 28% and 34% of limbs experienced limb loss at 6 and 12 months, respectively, compared with
10% and 15% of limbs in patients with an ABI >0.5 (P  .01). The only risk factor associated with wound closure was
initial wound size (P < .005).
Conclusions: Limb salvage can be achieved in most patients with arterial insufficiency and uncomplicated chronic
nonhealing limb ulcers using a program of wound management without revascularization. Healing proceeds slowly,
however, requiring more than a year in many cases. Patients with an ABI <0.5 are more likely to require amputation.
Interventions designed to improve outcomes in critical limb ischemia should stratify outcomes based on hemodynamic
data and should include a comparative control group given the natural history of ischemic ulcers treated in a dedicated
wound program. (J Vasc Surg 2006;44:108-14.)Patients presenting with chronic lower extremity ulcers
and arterial insufficiency are believed to be at high risk for
limb loss.1 Treatment usually involves an assessment for
revascularization, traditionally with surgical bypass or,
more recently, using endovascular methods when possible.
For those in whom revascularization is not possible or is not
warranted, primary amputation may be considered. Nu-
merous authors have documented excellent, long-term
limb salvage rates with successful revascularization, partic-
ularly with autogenous vein bypass procedures. However,
many patients with tissue loss and arterial insufficiency have
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108a limited life expectancy due to coexisting cardiac and other
medical conditions.2,3 For many of these patients, surgical
bypass may be risky, with a significant risk of morbidity or
mortality. Also, recovery to presurgical levels of function
does not occur in all patients.4,5
Several methods of percutaneous revascularization
have recently been developed for patients not generally
believed to be good candidates for endovascular proce-
dures, including those with infrapopliteal lesions and those
with extensive femoropopliteal disease. Reports of subinti-
mal recanalization,6 laser guided angioplasty,7 and atherec-
tomy devices8 have described favorable limb salvage in
patients with critical limb ischemia (CLI). Given the poor
outcome of patients treated with primary limb amputation,
associated with a high early mortality and limited ambula-
tory potential,9 endovascular procedures are being used
with increasing frequency for the treatment of CLI.
Absent from most discussions on the treatment of
patients presenting with CLI has been a comparison with
the natural history of CLI treated with currently available
noninterventional methods. Most physicians working in
wound management centers frequently see patients with
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endovascular procedures due to medical comorbidity, in-
stitutionalized nonambulatory status, or poor outflow ves-
sels in the limb. We have treated patients without extensive
tissue loss initially with local wound management and
report on the outcome of a cohort of patients with arterial
insufficiency and limb ulceration managed nonoperatively.
The goal is to provide information on the natural history of
this group of patients when they are treated with a dedi-
cated wound management plan.
METHODS
The study was a retrospective review of prospectively
collected case series and was approved by the Biomedical
Institutional Review Board at the University of North
Carolina School of Medicine.
Patients with nonhealing limb ulcers referred to the
University of North CarolinaWoundManagement Center,
an outpatient multispecialty wound center, are routinely
studied with a noninvasive Doppler evaluation of arterial
supply. Ankle and toe pressures are measured, and ankle-
brachial indexes (ABI) are calculated. Arterial insufficiency
was defined as an ABI index of0.7 or a toe pressure 50
mm Hg. CLI was defined in accordance with the TransAt-
lantic Inter-Society Consensus (TASC) recommendations
as an ankle pressure  70 mm Hg or a toe pressure  40
mm Hg.10
Those found to have arterial insufficiency were evalu-
ated by the vascular attending staff for suitability for percu-
taneous or surgical revascularization. Patients diagnosed
with arterial insufficiency and tissue loss who were poor
candidates for revascularization were followed prospec-
tively while receiving treatment using the wound manage-
ment protocol outlined in Table I (online only).
Patients were considered poor candidates for revascu-
larization due to severe medical comorbidity, nonambula-
tory status, inadequate outflow vessels, or patient/family
refusal. Although most patients do not have sufficiently
severe medical comorbidity to preclude endovascular revas-
cularization, patients with severe cardiac dysfunction have
an increased risk for surgical bypass. Ultimately, this judge-
ment was made in each individual case by the managing
vascular specialist.
Early in the time frame studied, patients with long-
segment femoral or tibial disease were not treated with
endovascular methods. More recently, with the emergence
of subintimal recanalization and other techniques, endo-
vascular therapies are used more frequently in this popula-
tion with a high incidence of diabetes mellitus and its
characteristic tibial artery disease. For surgical bypass, tibial
and pedal vessels were evaluated with contrast arteriogra-
phy. Any acceptable vessel  1 mm with runoff into pedal
collaterals was considered acceptable for surgical bypass,
including the dorsalis pedis and tarsal arteries.
Wounds were graded using the Wagner scale, which is
outlined in Table II (online only).11 Wounds were included
if they measured 1 cm in any dimension at the initial
evaluation. This protocol is a standard protocol for care oflimb ulcers used by many wound healing centers.12 Each
patient with arterial insufficiency and tissue loss was man-
aged primarily by a vascular specialist (W. A. M., M. A. F.,
R. C.M., B. A. K.). The outlined protocol provided general
guidelines for management, but specific treatment deci-
sions were made individually by the treating physician in
each case. In addition, active wound healing modalities,
including negative pressure therapy, platelet-derived
growth factor (PDGF), or bioengineered human skin
equivalents, were added in a small number of patients when
the treating physician believed they would accelerate
wound healing.
Definition of limb ischemia. Limbs were evaluated
for arterial supply by measuring ABIs, ankle pressures, toe
pressures, and Doppler waveforms. Criteria for study inclu-
sion were an ABI  0.7 or a toe pressure  50 mm Hg.
Transcutaneous oxygen and laser Doppler measurements
were available in a subset of patients but were not numerous
enough for statistical analysis.
Definition of chronic wound. Full-thickness ulcers
extending through the entire dermis into the subcutaneous
tissue present for a minimum of 6 weeks before initiation of
treatment were considered to be chronic wounds.
Exclusion criteria. Patients with Wagner grade 4
wounds were excluded from this study if tissue loss was
extensive. All Wagner grade 5 wounds were excluded.
Patients with necrotizing foot infections were also excluded
unless débridement and antibiotic therapy yielded a sal-
vageable foot. In the opinion of the investigators, most of
these patients require revascularization to have any chance
of limb salvage. Patients with tissue loss that was not
deemed salvageable by the treating physician were not
included. This included major exposure of the calcaneus or
sufficient tendon loss to prohibit useful function of the
foot. Patients were excluded if they did not follow-up at the
wound management center for at least 6 weeks of treat-
ment, unless follow-up was terminated due to amputation.
Because the source of patients for this study was an outpa-
tient clinic, some patients admitted directly to the hospital
from other sources with ischemic limb wounds were not
included unless follow-up occurred after discharge at the
wound center.
End points. The primary end point was the incidence
of major limb amputation (below or above knee) 1 year
after initiation of treatment. The secondary end point was
the incidence of wound closure 1 year after initiation of
treatment. Wound closure was defined as complete epithe-
lial coverage with no wound drainage identified at two
consecutive clinic visits.
Risk factors associated with an increased incidence of
amputation or reduced incidence of wound closure were
evaluated, including age, gender, race, history of diabetes
mellitus, history of significant renal insufficiency (serum
creatinine  2.5 mg/dL), initial wound grade by Wagner
scale, initial wound size, wound location, and severity of
ischemia as measured by ABI or toe pressure.
Statistical analysis. Descriptive statistics were ex-
pressed as mean  standard deviation. Satterthwaite un-
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between the means of the respective continuous variables
for amputated limbs compared with nonamputated and
healed limbs compared with unhealed. Spearman correla-
tions were performed to determine which risk factors were
associated with amputation or wound healing. Logistic
regression was used to assess the influence of multiple
covariates on the outcomes of interest (wound closure and
amputation), thereby determining which risk factors were
independently associated with these outcomes. For nonor-
dinal variables (wound location) the Mantel Haenszel 2
test was used to determine association with outcome. Out-
comemeasures over time are presented using Kaplan-Meier
life tables, with significance between groups measured us-
ing log-rank analysis.
RESULTS
Between January 1999 and March 2005, 169 limbs in
142 patients satisfied entry criteria to be followed in this
protocol. During the same time period, 382 limbs with
ischemic ulcerations underwent infrainguinal surgical by-
pass procedures, and 487 limbs received endovascular pro-
cedures for revascularization. Patients did not undergo
revascularization because of medical comorbidity (44%),
poor functional status (34%), inadequate outflow vessels
(14%), or patient/family refusal (8%). Demographic infor-
mation for the 142 patients is listed in Table III, and initial
wound characteristics are listed in Table IV. Outcome
information was obtained for 157 limbs at 6 months and
147 limbs at 12 months of treatment.
Toe amputations or other foot-sparing surgical proce-
dures were performed during treatment in 28% of limbs.
The standard protocol was used initially in all cases. During
follow-up treatment, advanced wound therapies were cho-
sen for treatment in 19% of limbs, using PDGF in 12% of
limb ulcers, negative pressure therapy in 4%, and bioengi-
neered human skin equivalents in 9%. Combinations of
these therapies were used in 6% of ulcers.
The primary end point of below or above knee ampu-
tation was reached overall in 37 limbs. At 1 year of follow-
up, 52% of limb ulcers were healed and 23% required
amputation. Life-table analyses of limb amputation and
ulcer closure are presented in Fig 1. Multivariate risk factor
Table III. Patient demographic information
Variable Percentage
Age 70.8  14.5 (38–93)*
Gender (male) 58.6
Race
African American 50.3
White 46.7
Hispanic 3.0
Diabetes mellitus 70.4
Renal insufficiency 27.8
Venous insufficiency 18.3
*Age in years  standard deviation (range)analyses revealed that ABI was independently associatedwith amputation at 1 year. At 12months, 32% of limbs with
an ABI 0.5 and 43% of limbs with an ABI 0.4 required
amputation compared with 15% of limbs with an ABI
between 0.5 and 0.7 (P  .01) (Fig 2). Ankle and toe
pressures were not predictive of amputation or wound
healing.
Eighty-six patients (51%) satisfied the TASC criteria for
CLI, and 38% of their limbs required amputation at 12
months. This incidence was significantly more frequent
than in the group with subcritical limb ischemia (n  83,
49%) in whom amputation occurred in 8.5% at 12 months
(P  .008 by log-rank testing). The frequency of ulcer
Table IV. Wound characteristics on initial evaluation
Limbs (n)*
Wound size, cm2 (range)† 8.4  20.3 (1-64)
Wound location
Toe 66
Heel 32
Dorsal foot 21
Plantar foot 12
Ankle 10
Calf area 28
Wound grade (by Wagner scale)
Grade 1 128
Grade 2 15
Grade 3 14
Grade 4 12
Best ABI (n  84) (mean) 0.48  0.15
Distribution
0–0.3 14
0.31–0.5 35
0.51–0.7 35
Toe pressure (n  85) (mean) 32.7  13.0 mm Hg
Distribution
0-20 19
21-40 39
41-50 27
Number of limbs meeting criteria for CLI 86 (51%)
ABI, Ankle-brachial index; CLI, critical limb ischemia.
*Except where noted, data are numbers of limbs.
†Determined by planimetry.
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in amputation less frequently than those with an initial
wound grade 3 or 4 by log-rank testing (P  .05) (Fig 3).
However, an insufficient number of patients with wound
grades 2, 3, and 4 were included to allow multivariate
analysis of wound grade as an independent predictor of
amputation. Categoric values for all variables and their
relationship with amputation are listed in Table V. Initial
ulcer size was the only risk factor independently associ-
ated with ulcer closure at 1 year. Categoric values for
variables and their relationship with wound healing are
listed in Table VI.
The relationship between wound location and amputa-
tion was evaluated using the Mantel-Haenszel test. The
data based on location are listed in Table VII. The rate of
amputation was higher in the heel, plantar, and dorsal foot
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tion.but did not reach statistical significance (P  .06).DISCUSSION
In a recent editorial for the Journal of Vascular Surgery,
Nehler, Hiatt, and Taylor noted that our understanding of
the natural history of CLI is limited and that the current
approach to CLI is excessively lesion-focused and inade-
quately patient-focused. They suggest that in some cases,
early amputation may be preferential to aggressive attempts
Table V. Risk factors and association with limb
amputation
Risk factor N
Amputated at 18 months,
n (%) P
Gender .38
Female 70 13 (18.6)
Male 99 24 (24.2)
Wound grade *
1 and 2 143 28 (19.6)
3 and 4 26 9 (34.6)
Diabetes mellitus .15
No 50 8 (16)
Yes 119 29 (24.4)
Venous .78
No 138 31 (22.5)
Yes 31 6 (19.4)
Renal insufficiency .81
No 122 23 (18.9)
Yes 47 14 (29.8)
Ankle-Brachial index .026
0.5 51 8 (15.7)
0.5 39 12 (30.8)
Toe pressure (mm Hg) .16
30 to 50 46 7 (15.2)
30 41 9 (22)
*P values are from multivariate logistic regression to determine indepen-
dent association of risk factor with amputation. Wound grade not studied
with multivariate analysis.
Table VI. Multivariate analysis of risk factors and
association with wound closure
Variable N Odds ratio P
Age 169 .06
Initial wound size 130 0.244 .003
Ankle-brachial index 90 .18
Treatment time 166 .11
Toe pressure 87 .7
Table VII. Wound location and incidence of amputation
Amputated (%) Not amputated (%) Total
Toe 12 (18.2) 54 (81.8) 66
Plantar foot 4 (7.3) 8 (14.7) 12
Dorsal foot 7 (33.30) 14 (66.7) 21
Heel 11 (34.4) 21 (65.6) 32
Ankle 1 (10.0) 9 (90.0) 10
Leg 2 (7.1) 26 (92.0) 28
Total 37 132 169at revascularization. However, data are currently lacking to
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with early amputation.13
Numerous recent studies have described methods for
treatment of specific types of arterial obstruction for CLI,
reporting success with high limb-salvage rates. Kudo et al14
reported that although primary patency for 138 limbs
treated with CLI using percutaneous transluminal angio-
plasty was only 31%, secondary patency was achieved in 80%
and limb salvage in 89%. They concluded that PTA is an
effective procedure for the treatment of CLI. Using exci-
mer laser assisted angioplasty (LACI), Bosiers et al7 treated
51 limbs with CLI, with a primary end point of limb
salvage. The rate of limb salvage at 6 months was 90.5%,
prompting the authors to recommend LACI for treatment
of accessible lesions in patients with CLI.7
Similar reports have recently been published describing
angioplasty and/or stenting,15 excisional atherectomy de-
vices,16 and subintimal recanalization,17 all with good ini-
tial success and favorable limb salvage results. Unfortu-
nately, none of these studies adhered to the hemodynamic
criteria for CLI outlined by the TASC, including only
patients with an ankle pressure 70 mm Hg or a toe
pressure 40 mm Hg.7,14-17 In some studies, preproce-
dure ankle pressures and ABIs were not reported, and in the
remainder, the average preintervention ABI was 0.4 to
0.54. It is likely that a significant number of limbs with
ankle pressures 70 were included. Patients with an ABI
0.5 are probably not at high risk for limb loss, so an
outcome measuring limb salvage in these patients is less
meaningful.
Similarly for surgical bypass, although a successful re-
vascularization yields a high rate of patency and limb sal-
vage at 5 years, significant morbidity and occasional mor-
tality are associated with the procedure.4,5 Some patients
are poor candidates due to medical comorbidity or unsuit-
able lower limb outflow vessels. Attempts at surgical revas-
cularization are not warranted if a patient group can be
defined with a high probability of healing without revascu-
larization. Unfortunately, neither studies of percutaneous
nor surgical revascularization have included patient groups
treated without revascularization for outcome comparison.
The goal of this study was to provide outcome infor-
mation from a cohort of patients with arterial insufficiency
and tissue loss treated without intervention. Approximately
half of the limbs in this study satisfied the hemodynamic
criteria for CLI outlined by the TASC. The rest had less
severe arterial insufficiency and were included to provide
outcome information on this patient group also.
Patients were identified in an outpatient clinic, so pa-
tients with acute, infected, or rapidly worsening ischemic
wounds that would typically present to an emergency de-
partment and require hospital admissionmay not have been
included. Many patients were institutionalized and nonam-
bulatory and might have been better treated with primary
amputation; however, families are often reluctant to con-
sent to amputation. In these cases, we used wound treat-
ment protocols to attempt to generate healing or at leastmaintain a wound in a stable, uncomplicated condition for
palliation.
Patients with extensive, complex wounds and those
with necrotizing infections were rarely treated without
revascularization. This, along with the patient recruitment
source, resulted in the low incidence of Wagner grade 3
and 4 wounds in this study. Ulcer size, however, was not a
limitation, as the average size was 8 cm2, with ulcers as
large as 64 cm2 included. For these reasons, we believe this
study describes the natural history of a segment of patients
with arterial insufficiency and tissue loss, particularly those
with noncomplicated ulcers.
The primary outcome revealed that most patients did
not require amputation, even those with more severe arte-
rial insufficiency; however, ulcer closure was slow, with only
25% closed at 6 months and just over 50% closed at a year.
In limbs where hemodynamic criteria were consistent with
CLI (as defined inMethods), the incidence of limb loss was
high—over a third at 1 year—so revascularization should
be performed whenever possible, but not so high that we
would recommend primary amputation on a routine basis.
In fact, we believe these data argue that patients who
cannot undergo revascularization should have a trial of
careful wound management before primary amputation,
even in those who are functionally impaired.
Several studies of pharmacologic therapies for CLI have
provided data on the natural history of patients with limb-
threatening ischemia. Three prospective placebo-controlled
studies that evaluated the use of iloprost for CLI reported an
average 39% incidence of limb loss in the control groups
treated without study medication,18-20 a rate similar to the
patient group in this study with hemodynamic criteria consis-
tent with CLI.
Previous studies of limb loss in patients with limb ulcers
have defined diabetes mellitus and renal insufficiency as risk
factors associated with amputation. We did not identify
these as risk factors, but this may be related to an inade-
quate patient sample size (47 patients with renal insuffi-
ciency, 50 patients without diabetes mellitus). The inci-
dence of limb loss for patients with renal insufficiency was
29.8% compared with 18.9% for those without renal insuf-
ficiency, but this difference did not reach statistical signifi-
cance.
Wound care using the protocol outlined in Table I
(online only) is labor intensive, expensive, and often re-
quires the patient to significantly limit activity levels. This
method of management would not be desirable for most
ambulatory patients if revascularization were feasible with-
out excessive risk. Successful revascularization would likely
result in more rapid healing and a more rapid return to
activity. Despite the effort required for 6 to 12 months of
outpatient wound management, we believe this is prefera-
ble to primary amputation for most patients.
In the group of patients who had hemodynamic criteria
consistent with subcritical stenosis, limb loss was less com-
mon. These patients should not typically be included in
critical limb ischemia studies in which limb salvage is a
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comparison.
We reviewed the ability of noninvasive Doppler studies
to predict the probability of limb loss. Although an ABI of
0.5 was a significant predictor for limb loss, valid ABIs
were obtainable in just over half of the limbs studied due to
the high incidence of severe diabetes mellitus with non-
compressible vessels. Unfortunately, neither ankle nor toe
pressures were predictive of limb loss or wound closure in
this patient population.
Other methods have been described to assist in predict-
ing the potential for wound healing, including transcuta-
neous pO2
21,22 and laser Doppler scans.23 Although we
currently use these methods, they were not available
throughout the study, and insufficient data were generated
to evaluate their predictive potential. Noninvasive methods
with a high sensitivity and specificity for predicting healing
without revascularization would greatly assist in patient
management.
Based on the results from this study, we believe that
patients should be considered for primary amputation
when the ABI is 0.5, with no potential for revasculariza-
tion and with extensive tissue loss. Although we could not
confirm that advanced wound grade is an independent
predictor of limb loss, it is likely that the study of a larger
group of patients would confirm this association. If tissue
loss is not extensive, initial care with a protocol similar to
that outlined in Table I (online only) may be recommended
and limb salvage expected in most patients.
The role for advanced wound-healing modalities such
as growth factors and bioengineered human skin equiva-
lents is unclear at this time. Less than one fourth of patients
were treated with these techniques in a nonrandomized
fashion, so their impact on healing is difficult to assess.
Current clinical trials evaluating newer growth factors are
actively enrolling patients with CLI and, it is hoped, will
yield therapies to assist in the treatment of these patients
when invasive procedures are not desirable.
CONCLUSION
In this study of a subset of patients with arterial insuf-
ficiency and uncomplicated, stable limb ulcers treated with-
out revascularization, major amputation was necessary in
23% of limbs at 12 months. Wound healing was slow but
eventually achieved in 52% at 12 months. We believe these
are acceptable outcomes for poor candidates for surgical or
endovascular intervention, so primary amputation should
not usually be considered in this patient group. Better
strategies for prediction of wound healing are needed be-
cause ABI and toe pressures are not useful for a large
percentage of patients. We believe that studies involving
interventions aimed at the treatment of CLI should include
only patients with severe hemodynamic arterial insuffi-
ciency as defined by the TASC, because the patients with
subcritical ischemia and tissue loss enrolled in this study had
a relatively low risk of limb loss without revascularization.We acknowledge the assistance ofWilliamCade,MPH,
and Gary Koch, PhD, of the University of North Carolina
Biostatistics Department, with the statistical analysis per-
formed for this manuscript.
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Volume 44, Number 1 Marston et al 114.e1Table I (online only). Protocol for management of limb ulcers associated with arterial insufficiency
Outpatient visit frequency weekly over first 4 weeks, then every 1 to 3 weeks
Wound documentation
Digital photography
Wound planimetry to determine wound area
Determination of wound grade by Wagner scale
Débridement
Sharp surgical removal of nonviable tissue and surrounding callus at each visit if necessary
Thick eschar removed only when separating at wound edges
Pressure offloading
Podiatry-directed use of appropriate offloading device based on wound location
Infection management
Topical agents rarely used
Débridement, deep culture, systemic antibiotics if increasing bioburden or infection is suspected clinically
Topical agents
Dressing products chosen to maintain moist wound bed, most often hydrogel/gauze or absorbent foam dressings
Table II (online only). Wagner grading scale for leg and foot ulcers
Grade 0
Preulcerative lesion, healed ulcers, bony deformity
Grade 1
Superficial ulcer, no subcutaneous tissue exposure
Grade 2
Penetration through the subcutaneous tissue (may expose bone, tendon, ligament, joint)
Grade 3
Osteitis, abscess, osteomyelitis
Grade 4
Gangrene of forefoot
Grade 5
Gangrene of entire foot
